What is Doceree?
Doceree operates as a global platform dedicated to building innovative solutions for healthcare professional (HCP) programmatic marketing, leveraging proprietary data tools. The company facilitates direct messaging between life sciences brands and HCPs by utilizing an extensive worldwide network of digital endemic and point-of-care platforms. This enables the programmatic delivery of personalized communications to HCPs, alongside transparent marketing campaign metrics at scale. The company's focus on data-driven personalization and transparent metrics positions it as a key player in the evolving digital health marketing landscape.
How much funding has Doceree raised?
Doceree has raised a total of $59.6M across 4 funding rounds:
Debt
$26K
Series A
$11M
Series B
$35M
Series B
$13.6M
Debt (2021): $26K with participation from PPP
Series A (2022): $11M led by Eight Roads, Alkemi International, and F-Prime Capital Partners
Series B (2023): $35M supported by Eight Roads and F-Prime Capital Partners
Series B (2024): $13.6M, investors not publicly disclosed
Key Investors in Doceree
Eight Roads
Eight Roads is a venture capital investment company based in Kent, specializing in real estate, venture, and growth businesses, indicating a strategic interest in Doceree's expansion.
F-Prime Capital Partners
F-Prime Capital Partners, located in Massachusetts, is a venture capital firm with a dedicated team focused on investing in healthcare and technology, aligning with Doceree's innovative approach.
Alkemi International
Alkemi International, an Australian online marketing agency, brings expertise in conversion rate optimization and verifiable results, suggesting a focus on the performance and impact of Doceree's marketing solutions.
What's next for Doceree?
With this major enterprise-level funding, Doceree is poised for accelerated growth and further innovation in its programmatic marketing solutions for the healthcare sector. The strategic investment will likely fuel the expansion of its global network, enhance its proprietary data tools, and deepen its capabilities in delivering personalized communications to healthcare professionals. This capital infusion signals strong investor confidence in Doceree's business model and its potential to disrupt traditional HCP marketing strategies, paving the way for broader market penetration and the development of next-generation advertising technologies within the life sciences industry.
See full Doceree company page
